Atlas Trials

Clinical Study to Assess the Long-term Safety, Tolerability, and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome

Clinical trial NCT01739400 · TERMINATED

Trial details

NCT number
NCT01739400
Sponsor
Actelion
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2013-09-10
Primary completion
2018-01-12
Enrollment
217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.